New Treatment Boosts Survival Rate for Deadly Brain Cancer

Topic: Health

Researchers at Oregon State University developed a new treatment that increased survival rate by 50% in mice with glioblastoma. The treatment uses sugar-coated nanoparticles to deliver genetic material that helps prevent tumor growth.

Glioblastoma is the most aggressive form of brain cancer, affecting only 3.19 people per 100,000 in the United States. Fewer than 30% of patients survive for two years after diagnosis. Researchers at Oregon State University have developed a new treatment that could change this statistic.

The team, led by Oleh Taratula, Olena Taratula, and Yoon Tae Goo, focused on two major problems that limit glioblastoma treatment: crossing the blood-brain barrier and reaching tumor cells without affecting healthy tissue. They created sugar-coated nanoparticles filled with genetic material designed to restore the body's ability to suppress tumor growth.

The sugar used in the coating was mannose, which is closely related to glucose, the body's main energy source. The researchers added a positively charged cholesterol derivative to protect the genetic material from breaking down before it reached its target.

In a mouse model, the treatment increased median survival time by 50% in mice with glioblastoma. The sugar-coated particles accumulated more heavily in tumors after crossing into the brain because glioblastoma cells produce unusually high levels of GLUT1, a transporter that normally carries glucose into the central nervous system.

The researchers' innovation was to chemically connect mannose to cholesterol, improving surface coverage sixfold. This allowed the nanoparticles to use the same pathway as glucose to cross the blood-brain barrier.

Why It Matters

This breakthrough could lead to new treatments for glioblastoma patients in India, where brain cancer is a significant health concern. The research also highlights the importance of innovative thinking and collaboration in finding solutions to complex medical problems.

Key Facts

• Glioblastoma affects only 3.19 people per 100,000 in the United States.
• Fewer than 30% of patients survive for two years after diagnosis.
• The new treatment increased median survival time by 50% in mice with glioblastoma.
• The sugar used in the coating was mannose, which is closely related to glucose.
• The researchers added a positively charged cholesterol derivative to protect the genetic material.

Key Terms

Blood-brain barrier

A tightly controlled network of cells that protects the central nervous system from substances circulating in the bloodstream.

GLUT1

A transporter that normally carries glucose into the central nervous system.

Implications

This breakthrough could lead to new treatments for glioblastoma patients in India, where brain cancer is a significant health concern. The research also highlights the importance of innovative thinking and collaboration in finding solutions to complex medical problems.